Evidence map›Paper›PMID 27165160›Full record

ArticleJournal of nephrology2017

Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.

Alessandro Roggeri, Daniela Paola Roggeri, Carlo Zocchetti, Maurizio Bersani, Ferruccio Conte, ReNe (Renal Lombardy Network), Additional contributors from ReNe Network

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alessandro RoggeriHealth Economics, ProCure Solutions, Via Camozzi 1/c, 24027, Nembro, Bergamo, Italy. alessandro.roggeri@procuresolutions.it.
Daniela Paola RoggeriHealth Economics, ProCure Solutions, Via Camozzi 1/c, 24027, Nembro, Bergamo, Italy.
Carlo ZocchettiRegional Health Authority, Lombardy Region, Milan, Italy.
Maurizio BersaniRegional Health Authority, Lombardy Region, Milan, Italy.
Ferruccio ConteNephrology Unit, S. Uboldo Hospital, Cernusco sul Naviglio, Italy.
ReNe (Renal Lombardy Network)
Additional contributors from ReNe Network
Regione LombardiaIstituto Sperimentale Modelli E Strutture · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) progression is associated with significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the treatment of CKD patients in the first year after starting hemodialysis and in the 2 years prior to dialysis.

methodsCitizens resident in the Lombardy Region (Italy) who initiated dialysis in the year 2011 (Jan 1 to Dec 31) were selected and data were extracted from Lombardy Regional databases on their direct healthcare costs in the first year after starting dialysis and in the 2 years prior to it was analyzed. Drugs, hospitalizations, diagnostic procedures and outpatient costs covered by RHS were estimated. Patients treated for acute kidney injury, or who died or stopped dialysis during the observational period were excluded.

resultsFrom the regional population (>9,700,000 inhabitants), 1067 patients (34.3 % females) initiating dialysis were identified, of whom 82 % underwent only hemodialysis (HD), 13 % only peritoneal dialysis (PD) and the remaining 5 % both treatments. Direct healthcare costs/patient were € 5239, € 12,303 and € 38,821 (€ 40,132 for HD vs. € 30,444 for PD patients) for the periods 24-12 months pre-dialysis, 12-0 months pre-dialysis, and in the first year of dialysis, respectively.

conclusionsThis study highlights a significant economic burden related to CKD and an increase in direct healthcare costs associated with the start of dialysis, pointing to the importance of prevention programs and early diagnosis.

Indexed as

Health Care CostsAdministrative Claims, HealthcareAgedAmbulatory CareDatabases, FactualDiagnostic Tests, RoutineDisease ProgressionDrug CostsFemaleHospital CostsHumansItalyMaleMiddle AgedModels, EconomicPeritoneal DialysisAdministrative dataChronic kidney diseaseCostDialysis

Identifiers

PMID27165160
OpenAlexW2376395117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.